PHARGENTIS AT A GLANCE

HEADQUARTERS

Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland.

Founded in 2015 and headquartered in Lugano.

FOUNDERS

Founders with more than 40 years experience in Pharmaceutical field.

Part of the privately owned group Chemholding SA.

WHAT WE DO

We develop complex dosage forms enabling Early Market Entry Generic Drugs and innovative SuperGeneric products.We deal with licensing-out to leading Pharma partners worldwide for market access.

CORE THERAPIES

We work actively to create a robust portfolio of treatments to address Respiratory Diseases and we foresee future expansion in Oncology.

PHARGENTIS IN DETAILS

Phargentis SA is a privately owned Virtual Drug Development Company located in Switzerland.

  • Incorporated in September 2015
  • Our mission is:
    • Development of complex dosage forms enabling Generic Drugs Early Market Entry
    • Development of innovative SuperGeneric products
    • Licensing-out to leading Pharma partners world-wide for market access

API supply secured mainly (but not only) from Cerbios-Pharma, leveraging sister company long-term expertise in the development and production of drug substances with strong focus on innovation and IP generation.